Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Transcode Therapeutics, Inc. | 180,262 | reported | 28 Sept 2023 | tx 11+1,209,607 |
Average stock performance after each discretionary buy, measured at 1, 3 and 6 months. 7 buys in history.
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 28 Sept 2023 | PURCHASE | Transcode Therapeutics, Inc. | 98,000 | 0.51 USD | |
| 21 Jun 2023 | PURCHASE | Transcode Therapeutics, Inc. | 12,000 | 2.65 USD | |
| 20 Jun 2023 | PURCHASE | Transcode Therapeutics, Inc. | 6,607 | 2.55 USD | |
| 09 Jun 2023 | PURCHASE | Transcode Therapeutics, Inc. | 19,000 | 2.76 USD | |
| 19 May 2023 | GRANT_AWARD | Transcode Therapeutics, Inc. | 735,000 | 0.00 USD | deriv |
| 12 Dec 2022 | GRANT_AWARD | Transcode Therapeutics, Inc. | 135,000 | 0.00 USD | deriv |
| 14 Sept 2022 | PURCHASE | Transcode Therapeutics, Inc. | 20,000 | 1.15 USD | |
| 27 May 2022 | PURCHASE | Transcode Therapeutics, Inc. | 28,000 | 1.84 USD | |
| 31 May 2022 | PURCHASE | Transcode Therapeutics, Inc. | 2,000 | 1.87 USD | |
| 01 Feb 2022 | GRANT_AWARD | Transcode Therapeutics, Inc. | 135,000 | 0.00 USD | deriv |